Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boston gains FDA OK for bile duct stent:

This article was originally published in Clinica

Executive Summary

Boston Scientific has gained US FDA clearance to sell its Express biliary LD pre-mounted stent system for alleviating malignant biliary obstruction - a blockage in any ducts that carries bile from the liver to the gallbladder and on to the small intestine. The system incorporates Boston's Tandem Architecture stent design with Ultra-thin SDS balloon catheter technology. The low profile, balloon-expandable stent comes in a wide range of sizes, says the Natick, Massachusetts firm.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT068812

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel